Cannabis Law Report

DECEMBER 2, 2021

(IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.

Clinical Trials 52

Clinical Trials Data Patients THC 52

CannaMD

OCTOBER 7, 2019

In 2011, researchers published cross-sectional data from two population-based surveys including over 50,000 respondents. Analyzing a collection of similar research, Cannabis and Cannabinoid Research summarizes: Across these studies, on average, cannabis users consumed an additional 834?calories/day Believe it or not, science says: YES.

Marijuana 105

Marijuana Cannabinoids Patients Conditions 105

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. a leading biotech company in the hemp and cannabis industries. in/ronanlevy/. The Third Wave.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51